Form 4: Quaker Chemical Director Jeffry D. Frisby Reports Routine Stock Unit Vesting and New Grant

Sentiment:

Insider Transaction Report


Quaker Chemical Corp. Director Jeffry D. Frisby reported the vesting of restricted stock units and dividend equivalent rights, along with the grant of new time-based restricted stock units as part of his 2025 compensation.

Summary

  • On May 31, 2025, Jeffry D. Frisby, a Director of Quaker Chemical Corp. (KWR), acquired 716 shares of common stock upon the vesting of restricted stock units.
  • Concurrently on May 31, 2025, Mr. Frisby also acquired 9 shares of common stock from the settlement of dividend equivalent rights associated with the vested restricted stock units.
  • Following these transactions, Mr. Frisby's direct beneficial ownership of Quaker Chemical common stock increased to 6,082 shares.
  • On June 1, 2025, Mr. Frisby was granted 1,198 new time-based restricted stock units under the Company's Long-Term Performance Incentive Plan, as part of his 2025 non-executive director compensation.
  • These newly granted restricted stock units are scheduled to vest 100% on May 31, 2026, and will accrue dividend equivalent rights.

Sentiment

Score: 7

Explanation: The document reports routine and expected insider transactions related to compensation, indicating stability in director remuneration and alignment with company performance through equity awards. There are no negative or unexpected elements.

Positives

  • The vesting of 716 restricted stock units and 9 dividend equivalent rights indicates a successful completion of prior compensation awards for the director.
  • The grant of 1,198 new restricted stock units demonstrates ongoing compensation and alignment of the director's interests with shareholder value through equity awards.

Future Outlook

The newly granted 1,198 restricted stock units are expected to vest 100% on May 31, 2026, indicating future share issuance to the director upon vesting.

Industry Context

This Form 4 filing details routine insider compensation and equity vesting, which is a standard practice across publicly traded companies to align executive and director interests with long-term shareholder value. It does not provide broader industry trends or competitive insights.

Stakeholder Impact

  • Shareholders: The issuance of shares upon vesting of restricted stock units represents a minor dilution, but it is a standard component of director compensation designed to align interests.
  • Employees: No direct impact mentioned, as this filing pertains to director compensation.

Next Steps

  • The 1,198 restricted stock units granted on June 1, 2025, are expected to vest on May 31, 2026, at which point they will convert into common stock.

Key Dates

DateDescription
06/01/2024Grant date for previously vested time-based restricted stock units.
05/31/2025Vesting date for 716 restricted stock units and settlement date for 9 dividend equivalent rights; also the transaction date for the acquisition of common stock.
06/01/2025Grant date for 1,198 new time-based restricted stock units as part of 2025 compensation.
06/03/2025Signature date of the Form 4 filing.
05/31/2026Scheduled vesting date for the 1,198 restricted stock units granted on June 1, 2025.

Keywords

Quaker Chemical Corp, KWR, Jeffry D. Frisby, Form 4, SEC filing, insider transaction, restricted stock units, RSU, dividend equivalent rights, director compensation, equity awards, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.